News APP

NewsApp (Free)

Read news as it happens
Download NewsApp

Available on  gplay

This article was first published 8 years ago
Home  » Sports » 'Don't want to end my career this way...hope I'll be given another chance'

'Don't want to end my career this way...hope I'll be given another chance'

March 08, 2016 02:28 IST
Get Rediff News in your Inbox:

Maria Sharapova of Russia looks on during a practice session

IMAGE: Maria Sharapova of Russia in a pensive mood during a match. Photograph: Clive Brunskill/Getty Images

Former tennis world number one Maria Sharapova said on Monday that she failed a drug test at the Australian Open due to a substance she has been taking the last 10 years for health issues.

The 28-year-old Russian, a five-times grand slam champion, tested positive for meldonium, which is used to treat diabetes and low magnesium, and was only banned by the World Anti-Doping Agency as of Jan. 1.

"I made a huge mistake. I let my fans down and I let the sport down. I have been playing since the age of four a sport that I love so deeply," Sharapova told a news conference in Los Angeles.

"I know that with this I face consequences and I don't want to end my career this way. I really hope that I will be given another chance to play this game."

The stunning news came a day after Sharapova's management team said she was going to make a "major announcement," which had many speculating that she was going to announce her retirement from professional tennis.

Sharapova, who has struggled with a series of injuries in recent years, has not competed since she lost to Serena Williams in the quarter-finals of the Australian Open in January.

"I was first given the substance back in 2006. I had several health issues going on at the time," said Sharapova.

"I was getting sick very often … and I had a deficiency in magnesium and a family history of diabetes, and there were signs of diabetes. That is one of the medications, along with others, that I received."

Get Rediff News in your Inbox:
Source: REUTERS
© Copyright 2024 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

New Zealand's tour of India 2024

New Zealand's Tour Of India, 2024